NCT07302776 2025-12-24
TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
Stanford University
Phase 1 Not yet recruiting
Stanford University
M.D. Anderson Cancer Center
University of Arizona
Gruppo Italiano Malattie EMatologiche dell'Adulto
Assiut University
Assiut University
Guangdong Provincial People's Hospital